74 related articles for article (PubMed ID: 7373039)
1. Stability of DNA/anti-DNA complexes. III. Kinetic control of immune complex size.
Taylor RP; Waller SJ; Haden C; Addis DJ
J Immunol; 1980 Jun; 124(6):2571-7. PubMed ID: 7373039
[TBL] [Abstract][Full Text] [Related]
2. Stability of DNA/anti-DNA complexes. II. Salt lability and avidity.
Riley RL; Addis DJ; Taylor RP
J Immunol; 1980 Jan; 124(1):1-7. PubMed ID: 6985634
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
Horgan C; Burge J; Crawford L; Taylor RP
J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus.
Nezlin R; Alarcón-Segovia D; Shoenfeld Y
J Autoimmun; 1998 Oct; 11(5):489-93. PubMed ID: 9802934
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
Medof ME; Prince GM; Oger JJ
Clin Exp Immunol; 1982 Jun; 48(3):715-25. PubMed ID: 7116690
[TBL] [Abstract][Full Text] [Related]
6. Human platelet-immune complex interaction in plasma.
Clark WF; Tevaarwerk GJ; Reid BD
J Lab Clin Med; 1982 Dec; 100(6):917-31. PubMed ID: 6982951
[TBL] [Abstract][Full Text] [Related]
7. Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.
Smeenk R; van der Lelij G; Aarden L
J Immunol; 1982 Jan; 128(1):73-8. PubMed ID: 7033379
[TBL] [Abstract][Full Text] [Related]
8. The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies.
Taylor RP; Kujala G; Edberg JC; Foreman P; Davis JS; Wright E
J Immunol; 1986 May; 136(10):3785-92. PubMed ID: 3701061
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.
Taylor RP; Kujala G; Wilson K; Wright E; Harbin A
J Immunol; 1985 Apr; 134(4):2550-8. PubMed ID: 3919101
[TBL] [Abstract][Full Text] [Related]
10. Antigen-antibody complexes produced in chickens tolerant to bovine serum albumin.
Eardley DD; Tempelis CH
J Immunol; 1975 Sep; 115(3):719-23. PubMed ID: 1151075
[TBL] [Abstract][Full Text] [Related]
11. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.
Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G
J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175
[TBL] [Abstract][Full Text] [Related]
12. Soluble oligovalent antigen--antibody complexes. II. The effect of various selective forces upon relative stability of isolated complexes.
Knutson DW; van Es LA; Kayser BS; Glassock RJ
Immunology; 1979 Jun; 37(2):495-503. PubMed ID: 468313
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes II. Influence of the size of the complexes.
Lamers MC; De Groot ER; Roos D
Eur J Immunol; 1981 Oct; 11(10):764-8. PubMed ID: 7308286
[TBL] [Abstract][Full Text] [Related]
14. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.
Yu L; Wang J; O'Dell JR; Oates J; Arend WP; Eisenbarth GS
J Rheumatol; 2007 Apr; 34(4):734-9. PubMed ID: 17407230
[TBL] [Abstract][Full Text] [Related]
15. Stability of DNA/ANTI-DNA complexes. IV. Complement fixation.
Pedersen SE; Taylor RP; Morley KW; Wright EL
J Immunol Methods; 1980; 38(3-4):269-80. PubMed ID: 7440976
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
18. Characterization of DNA antigens from immune complexes deposited in the skin of patients with systemic lupus erythematosus.
Zeng FQ; Yin RF; Tan GZ; Guo Q; Xu DQ
Chin Med J (Engl); 2004 Jul; 117(7):1066-71. PubMed ID: 15265384
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity against nucleosomes and lupus nephritis.
Van Bruggen MC; Kramers C; Berden JH
Ann Med Interne (Paris); 1996; 147(7):485-9. PubMed ID: 9092359
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
Voss A; Nielsen EH; Svehag SE; Junker P
J Rheumatol; 2008 Apr; 35(4):625-30. PubMed ID: 18278838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
